Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
16 August, 2018 02:53 IST
Lupin receives nod for generic Nitrofurantoin capsules
Source: IRIS | 12 Jul, 2018, 12.39PM
Comments  |  Post Comment

Lupin's Nitrofurantoin Capsules USP (Macrocrystals), 50 mg and 100 mg is the generic version of Alvogen Malta Operations Macrodantin Capsules, 50 mg and 100 mg. It is specifically indicated for the treatment of urinary tract infections when due to susceptible strains of Escherichia coli, enterococci, Staphylococcus aureus, and certain susceptible strains of Klebsiella and Enterobacter species.



Lupin Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
TCS named leader in KYC-AML BPO services by Everest Group - 14-Aug-2018 12:04
MCX to commence trading in rubber futures on August 16 - 14-Aug-2018 11:53
Cadila Healthcare acquires 51% stake in Windlas Healthcare - 13-Aug-2018 15:52
RCom re-instates bank guarantees of Rs 7.74 bn with DOT - 13-Aug-2018 12:08
Larsen & Tubro wins construction order worth Rs 30.28 bn - 13-Aug-2018 11:51
Tata Motors Group global wholesales at 92,639 in July'18 - 13-Aug-2018 10:32
Edelweiss Group to acquire two funds from Milestone Capital - 13-Aug-2018 10:01
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer